Virological Non-Suppression among Newly Diagnosed HIV-Positive Individuals on Dolutegravir-Based Antiretroviral Treatment in Eastern Ethiopia: Follow-Up Study

Virological Non-Suppression among Newly Diagnosed HIV-Positive Individuals on Dolutegravir-Based Antiretroviral Treatment in Eastern Ethiopia: Follow-Up Study

There have been limited studies linking baseline factors, including the viral load (VL) test, with virological non-suppression since the introduction of dolutegravir (DTG)-based regimens as first-line antiretroviral treatment (ART) in Ethiopia. This study aimed to identify baseline factors associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdella Gemechu, Adane Mihret, Fekadu Alemu Atire, Abraham Aseffa, Rawleigh Howe, Berhanu Seyoum, Andargachew Mulu
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2023-07-01
Colección:Tropical Medicine and Infectious Disease
Materias:
virological non-suppression
HIV
predictors
baseline viral load
eastern Ethiopia
Acceso en línea:https://www.mdpi.com/2414-6366/8/8/391

Internet

https://www.mdpi.com/2414-6366/8/8/391

Ejemplares similares